| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000038797 |
| Receipt No. | R000044223 |
| Scientific Title | Effects of an Ultrasound Focusing Device for Noncontact Force Radiation on Hair. |
| Date of disclosure of the study information | 2019/12/05 |
| Last modified on | 2021/06/07 (Ver. 2) |
| Basic information | ||
| Public title | Effects of an Ultrasound Focusing Device for Noncontact Force Radiation on Hair. | |
| Acronym | Effects of an Ultrasound Focusing Device for Noncontact Force Radiation on Hair. | |
| Scientific Title | Effects of an Ultrasound Focusing Device for Noncontact Force Radiation on Hair. | |
| Scientific Title:Acronym | Effects of an Ultrasound Focusing Device for Noncontact Force Radiation on Hair. | |
| Region |
|
|
| Condition | ||
| Condition | N/A(healthy adults) | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study aims to examine effects of an ultrasound focusing device for noncontact force radiation for hair. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | [1]Analysis of the number of hairs, the hair density, and the anagen:telogen ratio with TrichoScan (Week 0 and just after hair cutting, Week 0 and 3 days after hair cutting, Week 16 and just after hair cutting, Week 16 and 3 days after hair cutting). |
| Key secondary outcomes | *Secondary outcomes
[1]Gene expression test on a hair cycle (Week 0 and just after hair cutting, Week 16 and just after hair cutting). [2]Questionnaire of physical feeling (Week 0 and just after hair cutting, Week 16 and just after hair cutting). *Safety [1]Visual examination of head by a medical doctor (Screening, Week 0 and just after hair cutting, Week 16 and just after hair cutting). [2]Doctor's questions (Screening, Week 0 and just after hair cutting, Week 16 and just after hair cutting). [2]Subject's diary (From the first day of ingestion of a test material to the last day of the test). |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Radiating an ultrasound on measurement point (20 minutes / time; 16 times). | |
| Interventions/Control_2 | Nonradiating an ultrasound on measurement point (20 minutes / time; 16 times). | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | [1]Healthy Japanese females aged 20-29 years.
[2]Individuals who are healthy and have no chronic physical disease including skin disease. [3]Individuals whose working space is indoors. [4]Individuals whose written informed consent has been obtained. [5]Individuals who can have an examination on a designated check day. [6]Individuals judged appropriate for the study by the principal. |
|||
| Key exclusion criteria | [1]Individuals using medical products.
[2]Individuals with thinning hair or male pattern baldness. [3] Individuals with skin disease, such as atopic dermatitis on scalp. [4]Individuals who used a drug to treat Androgenetic Alopecia in the past 3 months. [5]Individuals who used a drug to treat a disease in the past 1 month. [6]Individuals who have a history of serious hepatopathy, kidney damage, heart disease, hematological and blood disease. [7]Individuals who contract or have a history of serious gastrointestinal disease. [8]Individuals whose BMI is over 30.0. [9]Individuals who have a habit to use a similar treatment with the test method or other hair growth promotion method. [10]Individuals who have an addiction to alcohol or a mental illness. [11]Individuals with possible changes of life style during the test period. [12]Individuals who participated in other clinical studies in the past 3 months. [13]Individuals judged inappropriate for the study by the principal. |
|||
| Target sample size | 12 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Ueno-Asagao Clinic | ||||||
| Division name | Head | ||||||
| Zip code | 110-0015 | ||||||
| Address | 6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN | ||||||
| TEL | +81-3-6240-1162 | ||||||
| info@ueno-asagao.clinc | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | TES Holdings Co., Ltd. | ||||||
| Division name | Administrative Department of Clinical Trials | ||||||
| Zip code | 110-0015 | ||||||
| Address | 6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN | ||||||
| TEL | +81-3-6801-8480 | ||||||
| Homepage URL | |||||||
| r.shimizu@tes-h.co.jp | |||||||
| Sponsor | |
| Institute | TES Holdings Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | ANGFA Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Ueno-Asagao Clinic Ethical Review Committee |
| Address | 6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN |
| Tel | +81-3-6240-1162 |
| jimukyoku@tes-h.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044223 |